Header Logo

Ali Keshavarzian

TitleProfessor
InstitutionRush University, Rush Medical College
DepartmentDigestive Diseases and Nutrition
Address1725 W. Harrison St.
Chicago IL 60612
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Other Positions:
    Josephine M. Dyrenforth Chair of Gastroenterology
    Professor of Medicine, Rush Medical College
    Professor, Graduate College
    Director, Division of Digestive Diseases & Nutrition
    Director, Institute for Advanced Study of the Gut, Chronobiology and Inflammation

    My Scopus ID is 7006447140.
    My NIH COMMONS name is AKESHAVARZIAN.

    Education:
    MD, Tehran University School of Medical Sciences, Iran, 1976

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Aboushaala K, Chee AV, Adnan D, Toro SJ, Singh H, Savoia A, Dhillon ES, Yuh C, Dourdourekas J, Patel IK, Vucicevic R, Espinoza-Orias AA, Martin JT, Oh C, Keshavarzian A, Albert HB, Karppinen J, Kocak M, Wong AYL, Goldberg EJ, Phillips FM, Colman MW, Williams FMK, Borgia JA, Naqib A, Green SJ, Forsyth CB, An HS, Samartzis D. Gut microbiome dysbiosis is associated with lumbar degenerative spondylolisthesis in symptomatic patients. JOR Spine. 2024 Dec; 7(4):e70005. PMID: 39398942; PMCID: PMC11467165.
      Citations:    
    2. Singh S, Giron LB, Shaikh MW, Shankaran S, Engen PA, Bogin ZR, Bambi SA, Goldman AR, Azevedo JLLC, Orgaz L, de Pedro N, Gonz?lez P, Giera M, Verhoeven A, S?nchez-L?pez E, Pandrea IV, Kannan T, Tanes CE, Bittinger K, Landay AL, Corley MJ, Keshavarzian A, Abdel-Mohsen M. Distinct Intestinal Microbial Signatures Linked to Accelerated Biological Aging in People with HIV. Res Sq. 2023 Oct 30. PMID: 37961645.
      Citations:    
    3. Post Z, Manfready RA, Keshavarzian A. Overview of the Gut-Brain Axis: From Gut to Brain and Back Again. Semin Neurol. 2023 08; 43(4):506-517. PMID: 37562457.
      Citations:    
    4. Bishehsari F, Drees M, Adnan D, Sharma D, Green S, Koshy J, Giron LB, Goldman A, Abdel-Mohsen M, Rasmussen HE, Miller GE, Keshavarzian A. Multi-omics approach to socioeconomic disparity in metabolic syndrome reveals roles of diet and microbiome. Proteomics. 2023 10; 23(19):e2300023. PMID: 37525324.
      Citations:    
    5. Boodaghidizaji M, Jungles T, Chen T, Zhang B, Landay A, Keshavarzian A, Hamaker B, Ardekani A. Machine learning based gut microbiota pattern and response to fiber as a diagnostic tool for chronic inflammatory diseases. bioRxiv. 2023 Mar 29. PMID: 37034781.
      Citations:    
    6. Boktor JC, Sharon G, Verhagen Metman LA, Hall DA, Engen PA, Zreloff Z, Hakim DJ, Bostick JW, Ousey J, Lange D, Humphrey G, Ackermann G, Carlin M, Knight R, Keshavarzian A, Mazmanian SK. Integrated Multi-Cohort Analysis of the Parkinson's Disease Gut Metagenome. Mov Disord. 2023 03; 38(3):399-409. PMID: 36691982.
      Citations:    
    7. Kleine Bardenhorst S, Cereda E, Severgnini M, Barichella M, Pezzoli G, Keshavarzian A, Desideri A, Pietrucci D, Aho VTE, Scheperjans F, Hildebrand F, Weis S, Egert M, Karch A, Vital M, R?bsamen N. Gut microbiota dysbiosis in Parkinson disease: A systematic review and pooled analysis. Eur J Neurol. 2023 Nov; 30(11):3581-3594. PMID: 36593694.
      Citations:    
    8. Ko FC, Jochum SB, Wilson BM, Adra A, Patel N, Lee H, Wilber S, Shaikh M, Forsyth C, Keshavarzian A, Swanson GR, Sumner DR. Colon epithelial cell-specific Bmal1 deletion impairs bone formation in mice. Bone. 2023 03; 168:116650. PMID: 36584784; PMCID: PMC9911378.
      Citations:    
    9. Jedel S, Beck T, Swanson G, Hood MM, Voigt RM, Gorenz A, Jakate S, Raeisi S, Hobfoll S, Keshavarzian A. Mindfulness Intervention Decreases Frequency and Severity of Flares in Inactive Ulcerative Colitis Patients: Results of a Phase II, Randomized, Placebo-Controlled Trial. Inflamm Bowel Dis. 2022 12 01; 28(12):1872-1892. PMID: 35661212.
      Citations:    
    10. Mavrogeni ME, Asadpoor M, Henricks PAJ, Keshavarzian A, Folkerts G, Braber S. Direct Action of Non-Digestible Oligosaccharides against a Leaky Gut. Nutrients. 2022 Nov 07; 14(21). PMID: 36364961.
      Citations:    
    11. Forsyth CB, Zhang L, Bhushan A, Swanson B, Zhang L, Mamede JI, Voigt RM, Shaikh M, Engen PA, Keshavarzian A, Forsyth CB, Zhang L, Bhushan A, Swanson B, Zhang L, Mamede JI, Voigt RM, Shaikh M, Engen PA, Keshavarzian A. The SARS-CoV-2 S1 Spike Protein Promotes MAPK and NF-kB Activation in Human Lung Cells and Inflammatory Cytokine Production in Human Lung and Intestinal Epithelial Cells. Microorganisms. 2022 Oct 10; 10(10). PMID: 36296272; PMCID: PMC9607240.
      Citations:    
    12. Giron LB, Peluso MJ, Ding J, Kenny G, Zilberstein NF, Koshy J, Hong KY, Rasmussen H, Miller GE, Bishehsari F, Balk RA, Moy JN, Hoh R, Lu S, Goldman AR, Tang HY, Yee BC, Chenna A, Winslow JW, Petropoulos CJ, Kelly JD, Wasse H, Martin JN, Liu Q, Keshavarzian A, Landay A, Deeks SG, Henrich TJ, Abdel-Mohsen M. Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-?B signaling. JCI Insight. 2022 09 22; 7(18). PMID: 36134654.
      Citations:    
    13. Manfready RA, Goetz CG, Keshavarzian A. Intestinal microbiota and neuroinflammation in Parkinson's disease: At the helm of the gut-brain axis. Int Rev Neurobiol. 2022; 167:81-99. PMID: 36427960.
      Citations:    
    14. Frausto DM, Engen PA, Naqib A, Jackson A, Tran L, Green SJ, Shaikh M, Forsyth CB, Keshavarzian A, Voigt RM. Impact of alcohol-induced intestinal microbiota dysbiosis in a rodent model of Alzheimer's disease. Front Aging. 2022; 3:916336. PMID: 36046496.
      Citations:    
    15. Voigt RM, Wang Z, Brown JM, Engen PA, Naqib A, Goetz CG, Hall DA, Metman LV, Shaikh M, Forsyth CB, Keshavarzian A. Gut microbial metabolites in Parkinson's disease: Association with lifestyle, disease characteristics, and treatment status. Neurobiol Dis. 2022 08; 170:105780. PMID: 35654277.
      Citations:    
    16. Jackson A, Engen PA, Forsyth CB, Shaikh M, Naqib A, Wilber S, Frausto DM, Raeisi S, Green SJ, Bradaric BD, Persons AL, Voigt RM, Keshavarzian A. Intestinal Barrier Dysfunction in the Absence of Systemic Inflammation Fails to Exacerbate Motor Dysfunction and Brain Pathology in a Mouse Model of Parkinson's Disease. Front Neurol. 2022; 13:882628. PMID: 35665034.
      Citations:    
    17. Swanson GR, Kochman N, Amin J, Chouhan V, Yim W, Engen PA, Shaikh M, Naqib A, Tran L, Voigt RM, Forsyth CB, Green SJ, Keshavarzian A. Disrupted Circadian Rest-Activity Cycles in Inflammatory Bowel Disease Are Associated With Aggressive Disease Phenotype, Subclinical Inflammation, and Dysbiosis. Front Med (Lausanne). 2021; 8:770491. PMID: 35265631.
      Citations:    
    18. Schugar RC, Gliniak CM, Osborn LJ, Massey W, Sangwan N, Horak A, Banerjee R, Orabi D, Helsley RN, Brown AL, Burrows A, Finney C, Fung KK, Allen FM, Ferguson D, Gromovsky AD, Neumann C, Cook K, McMillan A, Buffa JA, Anderson JT, Mehrabian M, Goudarzi M, Willard B, Mak TD, Armstrong AR, Swanson G, Keshavarzian A, Garcia-Garcia JC, Wang Z, Lusis AJ, Hazen SL, Brown JM. Gut microbe-targeted choline trimethylamine lyase inhibition improves obesity via rewiring of host circadian rhythms. Elife. 2022 01 24; 11. PMID: 35072627.
      Citations:    
    19. Wilson BM, Witkiewics BR, Voigt RM, Forysth CB, Keshavarzian A, Ko FC, Virdi AS, Sumner DR. Alcohol and Circadian Disruption Minimally Impact Bone Properties in Two Cohorts of Male Mice While Between-Cohort Differences Predominate: Association With Season of Birth? JBMR Plus. 2022 Mar; 6(3):e10591. PMID: 35309863; PMCID: PMC8914150.
      Citations:    
    20. Szklany K, Engen PA, Naqib A, Green SJ, Keshavarzian A, Lopez Rincon A, Siebrand CJ, Diks MAP, van de Kaa M, Garssen J, Knippels LMJ, Kraneveld AD. Dietary Supplementation throughout Life with Non-Digestible Oligosaccharides and/or n-3 Poly-Unsaturated Fatty Acids in Healthy Mice Modulates the Gut-Immune System-Brain Axis. Nutrients. 2021 Dec 30; 14(1). PMID: 35011046.
      Citations:    
    21. Pal G, Ramirez V, Engen PA, Naqib A, Forsyth CB, Green SJ, Mahdavinia M, Batra PS, Tajudeen BA, Keshavarzian A. Deep nasal sinus cavity microbiota dysbiosis in Parkinson's disease. NPJ Parkinsons Dis. 2021 Dec 08; 7(1):111. PMID: 34880258.
      Citations:    
    22. Jungles K, Tran TDB, Botha M, Rasmussen HE, Teixeira-Reis V, Sodergren E, Gray C, Lunjani N, Hlela C, Basera W, Hobane L, Watkins A, Engen P, Mankahla A, Gaunt B, Facey-Thomas H, Landay A, Weinstock GM, Keshavarzian A, Levin ME, Mahdavinia M. Association of gut microbiota and environment in children with AD, comparison of three cohorts of children. Clin Exp Allergy. 2022 03; 52(3):447-450. PMID: 34786779.
      Citations:    
    23. Bhalla S, Sharma B, Smith D, Boley R, McCluskey C, Ilyas Y, Afshar M, Balk R, Karnik N, Keshavarzian A. Investigating Unhealthy Alcohol Use As an Independent Risk Factor for Increased COVID-19 Disease Severity: Observational Cross-sectional Study. JMIR Public Health Surveill. 2021 11 05; 7(11):e33022. PMID: 34665758.
      Citations:    
    24. Moran MM, Wessman P, Rolfson O, Bohl DD, K?rrholm J, Keshavarzian A, Sumner DR. The risk of revision following total hip arthroplasty in patients with inflammatory bowel disease, a registry based study. PLoS One. 2021; 16(11):e0257310. PMID: 34735461; PMCID: PMC8568118.
      Citations:    
    25. Giron LB, Dweep H, Yin X, Wang H, Damra M, Goldman AR, Gorman N, Palmer CS, Tang HY, Shaikh MW, Forsyth CB, Balk RA, Zilberstein NF, Liu Q, Kossenkov A, Keshavarzian A, Landay A, Abdel-Mohsen M. Corrigendum: Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients. Front Immunol. 2021; 12:779064. PMID: 34671365.
      Citations:    
    26. Alsayid M, Khan MO, Adnan D, Rasmussen HE, Keshavarzian A, Bishehsari F. Behavioral circadian phenotypes are associated with the risk of elevated body mass index. Eat Weight Disord. 2022 May; 27(4):1395-1403. PMID: 34355307.
      Citations:    
    27. Landay A, Bartley J, Banerjee D, Hargis G, Haynes L, Keshavarzian A, Kuo CL, Kwon OS, Li S, Li S, Oh J, Ozbolat IT, Ucar D, Xu M, Yao X, Unutmaz D, Kuchel GA. Network Topology of Biological Aging and Geroscience-Guided Approaches to COVID-19. Front Aging. 2021 Jul; 2. PMID: 35128530.
      Citations:    
    28. Cantu-Jungles TM, Bulut N, Chambry E, Ruthes A, Iacomini M, Keshavarzian A, Johnson TA, Hamaker BR. Dietary Fiber Hierarchical Specificity: the Missing Link for Predictable and Strong Shifts in Gut Bacterial Communities. mBio. 2021 06 29; 12(3):e0102821. PMID: 34182773.
      Citations:    
    29. Giron LB, Dweep H, Yin X, Wang H, Damra M, Goldman AR, Gorman N, Palmer CS, Tang HY, Shaikh MW, Forsyth CB, Balk RA, Zilberstein NF, Liu Q, Kossenkov A, Keshavarzian A, Landay A, Abdel-Mohsen M. Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients. Front Immunol. 2021; 12:686240. PMID: 34177935.
      Citations:    
    30. Engen PA, Naqib A, Jennings C, Green SJ, Landay A, Keshavarzian A, Voigt RM. Nasopharyngeal Microbiota in SARS-CoV-2 Positive and Negative Patients. Biol Proced Online. 2021 Jun 01; 23(1):10. PMID: 34058978.
      Citations:    
    31. Adeniji OS, Giron LB, Purwar M, Zilberstein NF, Kulkarni AJ, Shaikh MW, Balk RA, Moy JN, Forsyth CB, Liu Q, Dweep H, Kossenkov A, Weiner DB, Keshavarzian A, Landay A, Abdel-Mohsen M. COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions. mBio. 2021 04 20; 12(2). PMID: 33879594.
      Citations:    
    32. Abbring S, Engen PA, Naqib A, Green SJ, Garssen J, Keshavarzian A, van Esch BCAM. Raw Milk-Induced Protection against Food Allergic Symptoms in Mice Is Accompanied by Shifts in Microbial Community Structure. Int J Mol Sci. 2021 Mar 26; 22(7). PMID: 33810380.
      Citations:    
    33. Albani G, Albani S, Keshavarzian A. Editorial: Role of Diet, Physical Activity and Immune System in Parkinson's Disease. Front Neurol. 2020; 11:611349. PMID: 33362707.
      Citations:    
    34. Bishehsari F, Engen PA, Adnan D, Sarrafi S, Wilber S, Shaikh M, Green SJ, Naqib A, Giron LB, Abdel-Mohsen M, Keshavarzian A. Abnormal food timing and predisposition to weight gain: Role of barrier dysfunction and microbiota. Transl Res. 2021 05; 231:113-123. PMID: 33221482.
      Citations:    
    35. Bishehsari F, Voigt RM, Keshavarzian A. Circadian rhythms and the gut microbiota: from the metabolic syndrome to cancer. Nat Rev Endocrinol. 2020 12; 16(12):731-739. PMID: 33106657.
      Citations:    
    36. van Kessel SP, de Jong HR, Winkel SL, van Leeuwen SS, Nelemans SA, Permentier H, Keshavarzian A, El Aidy S. Gut bacterial deamination of residual levodopa medication for Parkinson's disease. BMC Biol. 2020 10 20; 18(1):137. PMID: 33076930.
      Citations:    
    37. Moran MM, Wilson BM, Li J, Engen PA, Naqib A, Green SJ, Virdi AS, Plaas A, Forsyth CB, Keshavarzian A, Sumner DR. The gut microbiota may be a novel pathogenic mechanism in loosening of orthopedic implants in rats. FASEB J. 2020 11; 34(11):14302-14317. PMID: 32931052; PMCID: PMC8025663.
      Citations:    
    38. Engen PA, Zaferiou A, Rasmussen H, Naqib A, Green SJ, Fogg LF, Forsyth CB, Raeisi S, Hamaker B, Keshavarzian A. Single-Arm, Non-randomized, Time Series, Single-Subject Study of Fecal Microbiota Transplantation in Multiple Sclerosis. Front Neurol. 2020; 11:978. PMID: 33013647.
      Citations:    
    39. Joers V, Masilamoni G, Kempf D, Weiss AR, Rotterman TM, Murray B, Yalcin-Cakmakli G, Voll RJ, Goodman MM, Howell L, Bachevalier J, Green SJ, Naqib A, Shaikh M, Engen PA, Keshavarzian A, Barnum CJ, Nye JA, Smith Y, Tansey MG. Microglia, inflammation and gut microbiota responses in a progressive monkey model of Parkinson's disease: A case series. Neurobiol Dis. 2020 10; 144:105027. PMID: 32712266.
      Citations:    
    40. Bishehsari F, Preuss F, Mirbagheri SS, Zhang L, Shaikh M, Keshavarzian A. Interaction of alcohol with time of eating on markers of circadian dyssynchrony and colon tissue injury. Chem Biol Interact. 2020 Jul 01; 325:109132. PMID: 32437693.
      Citations:    
    41. Swanson GR, Siskin J, Gorenz A, Shaikh M, Raeisi S, Fogg L, Forsyth C, Keshavarzian A. Disrupted diurnal oscillation of gut-derived Short chain fatty acids in shift workers drinking alcohol: Possible mechanism for loss of resiliency of intestinal barrier in disrupted circadian host. Transl Res. 2020 07; 221:97-109. PMID: 32376406.
      Citations:    
    42. Bishehsari F, Zhang L, Voigt RM, Maltby N, Semsarieh B, Zorub E, Shaikh M, Wilber S, Armstrong AR, Mirbagheri SS, Preite NZ, Song P, Stornetta A, Balbo S, Forsyth CB, Keshavarzian A. Alcohol Effects on Colon Epithelium are Time-Dependent. Alcohol Clin Exp Res. 2019 09; 43(9):1898-1908. PMID: 31237690.
      Citations:    
    43. Moossavi S, Engen PA, Ghanbari R, Green SJ, Naqib A, Bishehsari F, Merat S, Poustchi H, Keshavarzian A, Malekzadeh R. Assessment of the impact of different fecal storage protocols on the microbiota diversity and composition: a pilot study. BMC Microbiol. 2019 06 28; 19(1):145. PMID: 31253096.
      Citations:    
    44. Fonseca TL, Fernandes GW, Bocco BMLC, Keshavarzian A, Jakate S, Donohue TM, Gereben B, Bianco AC. Hepatic Inactivation of the Type 2 Deiodinase Confers Resistance to Alcoholic Liver Steatosis. Alcohol Clin Exp Res. 2019 07; 43(7):1376-1383. PMID: 30908637.
      Citations:    
    45. Voigt RM, Forsyth CB, Keshavarzian A. Circadian rhythms: a regulator of gastrointestinal health and dysfunction. Expert Rev Gastroenterol Hepatol. 2019 May; 13(5):411-424. PMID: 30874451.
      Citations:    
    46. Mazzoccoli G, Keshavarzian A, Vinciguerra M. Hedgehog signaling keeps liver clock in check. J Hepatol. 2019 06; 70(6):1054-1056. PMID: 30826121.
      Citations:    
    47. Kaur A, Chen T, Green SJ, Mutlu E, Martin BR, Rumpagaporn P, Patterson JA, Keshavarzian A, Hamaker BR. Physical Inaccessibility of a Resistant Starch Shifts Mouse Gut Microbiota to Butyrogenic Firmicutes. Mol Nutr Food Res. 2019 04; 63(7):e1801012. PMID: 30659764.
      Citations:    
    48. Dodiya HB, Forsyth CB, Voigt RM, Engen PA, Patel J, Shaikh M, Green SJ, Naqib A, Roy A, Kordower JH, Pahan K, Shannon KM, Keshavarzian A. Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease. Neurobiol Dis. 2020 02; 135:104352. PMID: 30579705.
      Citations:    
    49. Perez-Pardo P, Dodiya HB, Engen PA, Forsyth CB, Huschens AM, Shaikh M, Voigt RM, Naqib A, Green SJ, Kordower JH, Shannon KM, Garssen J, Kraneveld AD, Keshavarzian A. Role of TLR4 in the gut-brain axis in Parkinson's disease: a translational study from men to mice. Gut. 2019 05; 68(5):829-843. PMID: 30554160.
      Citations:    
    50. Hood MM, Wilson R, Gorenz A, Jedel S, Raeisi S, Hobfoll S, Keshavarzian A. Sleep Quality in Ulcerative Colitis: Associations with Inflammation, Psychological Distress, and Quality of Life. Int J Behav Med. 2018 Oct; 25(5):517-525. PMID: 30159665.
      Citations:    
    51. Yu Y, Blokhuis BRJ, Diks MAP, Keshavarzian A, Garssen J, Redegeld FA. Functional Inhibitory Siglec-6 Is Upregulated in Human Colorectal Cancer-Associated Mast Cells. Front Immunol. 2018; 9:2138. PMID: 30294327.
      Citations:    
    52. Chen D, Xie R, Shu B, Landay AL, Wei C, Reiser J, Spagnoli A, Torquati A, Forsyth CB, Keshavarzian A, Sumner DR. Wnt signaling in bone, kidney, intestine, and adipose tissue and interorgan interaction in aging. Ann N Y Acad Sci. 2019 04; 1442(1):48-60. PMID: 30101565.
      Citations:    
    53. Bishehsari F, Zhang L, Barlass U, Preite NZ, Turturro S, Najor MS, Shetuni BB, Zayas JP, Mahdavinia M, Abukhdeir AM, Keshavarzian A. KRAS mutation and epithelial-macrophage interplay in pancreatic neoplastic transformation. Int J Cancer. 2018 10 15; 143(8):1994-2007. PMID: 29756386.
      Citations:    
    54. Rossi M, Mirbagheri SEYEDS, Keshavarzian A, Bishehsari F. Nutraceuticals in colorectal cancer: A mechanistic approach. Eur J Pharmacol. 2018 Aug 15; 833:396-402. PMID: 29935172.
      Citations:    
    55. Das V, Kc R, Li X, Varma D, Qiu S, Kroin JS, Forsyth CB, Keshavarzian A, van Wijnen AJ, Park TJ, Stein GS, O-Sullivan I, Burris TP, Im HJ. Corrigendum to "Pharmacological targeting of the mammalian clock reveals a novel analgesic for osteoarthritis-induced pain" [GENE 655 (2018) 1-12]. Gene. 2019 01 05; 680:105. PMID: 29890121.
      Citations:    
    56. Davis BT, Voigt RM, Shaikh M, Forsyth CB, Keshavarzian A. Circadian Mechanisms in Alcohol Use Disorder and Tissue Injury. Alcohol Clin Exp Res. 2018 04; 42(4):668-677. PMID: 29450896.
      Citations:    
    57. Xiao L, Van't Land B, Engen PA, Naqib A, Green SJ, Nato A, Leusink-Muis T, Garssen J, Keshavarzian A, Stahl B, Folkerts G. Human milk oligosaccharides protect against the development of autoimmune diabetes in NOD-mice. Sci Rep. 2018 03 01; 8(1):3829. PMID: 29497108.
      Citations:    
    58. Das V, Kc R, Li X, Varma D, Qiu S, Kroin JS, Forsyth CB, Keshavarzian A, van Wijnen AJ, Park TJ, Stein GS, O-Sullivan I, Burris TP, Im HJ. Pharmacological targeting of the mammalian clock reveals a novel analgesic for osteoarthritis-induced pain. Gene. 2018 May 20; 655:1-12. PMID: 29474860.
      Citations:    
    59. Bishehsari F, Engen PA, Preite NZ, Tuncil YE, Naqib A, Shaikh M, Rossi M, Wilber S, Green SJ, Hamaker BR, Khazaie K, Voigt RM, Forsyth CB, Keshavarzian A. Dietary Fiber Treatment Corrects the Composition of Gut Microbiota, Promotes SCFA Production, and Suppresses Colon Carcinogenesis. Genes (Basel). 2018 Feb 16; 9(2). PMID: 29462896.
      Citations:    
    60. Mahdavinia M, Engen PA, LoSavio PS, Naqib A, Khan RJ, Tobin MC, Mehta A, Kota R, Preite NZ, Codispoti CD, Tajudeen BA, Schleimer RP, Green SJ, Keshavarzian A, Batra PS. The nasal microbiome in patients with chronic rhinosinusitis: Analyzing the effects of atopy and bacterial functional pathways in 111 patients. J Allergy Clin Immunol. 2018 07; 142(1):287-290.e4. PMID: 29452201.
      Citations:    
    61. Rossi M, Jahanzaib Anwar M, Usman A, Keshavarzian A, Bishehsari F. Colorectal Cancer and Alcohol Consumption-Populations to Molecules. Cancers (Basel). 2018 Jan 30; 10(2). PMID: 29385712.
      Citations:    
    62. Collado MC, Engen PA, Band?n C, Cabrera-Rubio R, Voigt RM, Green SJ, Naqib A, Keshavarzian A, Scheer FAJL, Garaulet M. Timing of food intake impacts daily rhythms of human salivary microbiota: a randomized, crossover study. FASEB J. 2018 04; 32(4):2060-2072. PMID: 29233857.
      Citations:    
    63. Persons AL, Bradaric BD, Dodiya HB, Ohene-Nyako M, Forsyth CB, Keshavarzian A, Shaikh M, Napier TC. Colon dysregulation in methamphetamine self-administering HIV-1 transgenic rats. PLoS One. 2018; 13(1):e0190078. PMID: 29293553.
      Citations:    
    64. Davis BT, Voigt RM, Shaikh M, Forsyth CB, Keshavarzian A. CREB Protein Mediates Alcohol-Induced Circadian Disruption and Intestinal Permeability. Alcohol Clin Exp Res. 2017 Dec; 41(12):2007-2014. PMID: 28960346.
      Citations:    
    65. Voigt RM, Forsyth CB, Shaikh M, Zhang L, Raeisi S, Aloman C, Preite NZ, Donohue TM, Fogg L, Keshavarzian A. Diurnal variations in intestinal barrier integrity and liver pathology in mice: implications for alcohol binge. Am J Physiol Gastrointest Liver Physiol. 2018 01 01; 314(1):G131-G141. PMID: 29074484.
      Citations:    
    66. Gianella S, Chaillon A, Mutlu EA, Engen PA, Voigt RM, Keshavarzian A, Losurdo J, Chakradeo P, Lada SM, Nakazawa M, Landay AL. Effect of cytomegalovirus and Epstein-Barr virus replication on intestinal mucosal gene expression and microbiome composition of HIV-infected and uninfected individuals. AIDS. 2017 09 24; 31(15):2059-2067. PMID: 28906277.
      Citations:    
    67. Krarup AR, Abdel-Mohsen M, Schleimann MH, Vibholm L, Engen PA, Dige A, Wittig B, Schmidt M, Green SJ, Naqib A, Keshavarzian A, Deng X, Olesen R, Petersen AM, Benfield T, ?stergaard L, Rasmussen TA, Agnholt J, Nyengaard JR, Landay A, S?gaard OS, Pillai SK, Tolstrup M, Denton PW. The TLR9 agonist MGN1703 triggers a potent type I interferon response in the sigmoid colon. Mucosal Immunol. 2018 03; 11(2):449-461. PMID: 28766555.
      Citations:    
    68. Mahdavinia M, Rasmussen HE, Engen P, Van den Berg JP, Davis E, Engen K, Green SJ, Naqib A, Botha M, Gray C, Lunjani N, Hlela C, Basera W, Hobane L, Watkins A, Tobin MC, Landay A, Keshavarzian A, Levin ME. Atopic dermatitis and food sensitization in South African toddlers: Role of fiber and gut microbiota. Ann Allergy Asthma Immunol. 2017 06; 118(6):742-743.e3. PMID: 28583264.
      Citations:    
    69. Yang AM, Inamine T, Hochrath K, Chen P, Wang L, Llorente C, Bluemel S, Hartmann P, Xu J, Koyama Y, Kisseleva T, Torralba MG, Moncera K, Beeri K, Chen CS, Freese K, Hellerbrand C, Lee SM, Hoffman HM, Mehal WZ, Garcia-Tsao G, Mutlu EA, Keshavarzian A, Brown GD, Ho SB, Bataller R, St?rkel P, Fouts DE, Schnabl B. Intestinal fungi contribute to development of alcoholic liver disease. J Clin Invest. 2017 Jun 30; 127(7):2829-2841. PMID: 28530644.
      Citations:    
    70. Perez-Pardo P, Dodiya HB, Broersen LM, Douna H, van Wijk N, Lopes da Silva S, Garssen J, Keshavarzian A, Kraneveld AD. Gut-brain and brain-gut axis in Parkinson's disease models: Effects of a uridine and fish oil diet. Nutr Neurosci. 2018 Jul; 21(6):391-402. PMID: 28276272.
      Citations:    
    71. Engen PA, Dodiya HB, Naqib A, Forsyth CB, Green SJ, Voigt RM, Kordower JH, Mutlu EA, Shannon KM, Keshavarzian A. The Potential Role of Gut-Derived Inflammation in Multiple System Atrophy. J Parkinsons Dis. 2017; 7(2):331-346. PMID: 28234259.
      Citations:    
    72. Voigt RM, Forsyth CB, Green SJ, Engen PA, Keshavarzian A. Circadian Rhythm and the Gut Microbiome. Int Rev Neurobiol. 2016; 131:193-205. PMID: 27793218.
      Citations:    
    73. Yazici C, Arslan DC, Abraham R, Cushing K, Keshavarzian A, Mutlu EA. Breath Methane Levels Are Increased Among Patients with Diverticulosis. Dig Dis Sci. 2016 09; 61(9):2648-54. PMID: 27129485.
      Citations:    
    74. Burgess HJ, Rizvydeen M, Fogg LF, Keshavarzian A. A single dose of alcohol does not meaningfully alter circadian phase advances and phase delays to light in humans. Am J Physiol Regul Integr Comp Physiol. 2016 Apr 15; 310(8):R759-65. PMID: 26936778.
      Citations:    
    75. Patel AL, Mutlu EA, Sun Y, Koenig L, Green S, Jakubowicz A, Mryan J, Engen P, Fogg L, Chen AL, Pombar X, Meier PP, Keshavarzian A. Longitudinal Survey of Microbiota in Hospitalized Preterm Very-Low-Birth-Weight Infants. J Pediatr Gastroenterol Nutr. 2016 Feb; 62(2):292-303. PMID: 26230901.
      Citations:    
    76. Voigt RM, Summa KC, Forsyth CB, Green SJ, Engen P, Naqib A, Vitaterna MH, Turek FW, Keshavarzian A. The Circadian Clock Mutation Promotes Intestinal Dysbiosis. Alcohol Clin Exp Res. 2016 Feb; 40(2):335-47. PMID: 26842252.
      Citations:    
    77. Patel S, Behara R, Swanson GR, Forsyth CB, Voigt RM, Keshavarzian A. Alcohol and the Intestine. Biomolecules. 2015 Oct 15; 5(4):2573-88. PMID: 26501334.
      Citations:    
    78. Summa KC, Jiang P, Fitzpatrick K, Voigt RM, Bowers SJ, Forsyth CB, Vitaterna MH, Keshavarzian A, Turek FW. Chronic Alcohol Exposure and the Circadian Clock Mutation Exert Tissue-Specific Effects on Gene Expression in Mouse Hippocampus, Liver, and Proximal Colon. Alcohol Clin Exp Res. 2015 Oct; 39(10):1917-29. PMID: 26332085.
      Citations:    
    79. Keshavarzian A, Green SJ, Engen PA, Voigt RM, Naqib A, Forsyth CB, Mutlu E, Shannon KM. Colonic bacterial composition in Parkinson's disease. Mov Disord. 2015 Sep; 30(10):1351-60. PMID: 26179554.
      Citations:    
    80. Kc R, Voigt R, Li X, Forsyth CB, Ellman MB, Summa KC, Turek FW, Keshavarzian A, Kim JS, Im HJ. Induction of Osteoarthritis-like Pathologic Changes by Chronic Alcohol Consumption in an Experimental Mouse Model. Arthritis Rheumatol. 2015 Jun; 67(6):1678-80. PMID: 25708245.
      Citations:    
    81. Jedel S, Hood MM, Keshavarzian A. Getting personal: a review of sexual functioning, body image, and their impact on quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2015 Apr; 21(4):923-38. PMID: 25789923.
      Citations:    
    82. Shaikh M, Rajan K, Forsyth CB, Voigt RM, Keshavarzian A. Simultaneous gas-chromatographic urinary measurement of sugar probes to assess intestinal permeability: use of time course analysis to optimize its use to assess regional gut permeability. Clin Chim Acta. 2015 Mar 10; 442:24-32. PMID: 25591964.
      Citations:    
    83. Wisittipanit N, Rangwala H, Sikaroodi M, Keshavarzian A, Mutlu EA, Gillevet P. Classification methods for the analysis of LH-PCR data associated with inflammatory bowel disease patients. Int J Bioinform Res Appl. 2015; 11(2):111-29. PMID: 25786791.
      Citations:    
    84. Bashashati M, Habibi HR, Keshavarzian A, Schmulson M, Sharkey KA. Intestinal microbiota: a regulator of intestinal inflammation and cardiac ischemia? Curr Drug Targets. 2015; 16(3):199-208. PMID: 25601328.
      Citations:    
    85. Forsyth CB, Voigt RM, Burgess HJ, Swanson GR, Keshavarzian A. Circadian rhythms, alcohol and gut interactions. Alcohol. 2015 Jun; 49(4):389-98. PMID: 25499101.
      Citations:    
    86. Ben Musa R, Gampa A, Basu S, Keshavarzian A, Swanson G, Brown M, Abraham R, Bruninga K, Losurdo J, DeMeo M, Mobarhan S, Shapiro D, Mutlu E. Hepatitis B vaccination in patients with inflammatory bowel disease. World J Gastroenterol. 2014 Nov 07; 20(41):15358-66. PMID: 25386085.
      Citations:    
    87. Forsyth CB, Voigt RM, Keshavarzian A. Intestinal CYP2E1: A mediator of alcohol-induced gut leakiness. Redox Biol. 2014; 3:40-6. PMID: 25462064.
      Citations:    
    88. Chen P, Torralba M, Tan J, Embree M, Zengler K, St?rkel P, van Pijkeren JP, DePew J, Loomba R, Ho SB, Bajaj JS, Mutlu EA, Keshavarzian A, Tsukamoto H, Nelson KE, Fouts DE, Schnabl B. Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice. Gastroenterology. 2015 Jan; 148(1):203-214.e16. PMID: 25239591.
      Citations:    
    89. Tang Y, Forsyth CB, Keshavarzian A. The role of miRNAs in alcohol-induced endotoxemia, dysfunction of mucosal immunity, and gut leakiness. Alcohol Clin Exp Res. 2014 Sep; 38(9):2331-4. PMID: 25257284.
      Citations:    
    90. Voigt RM, Forsyth CB, Green SJ, Mutlu E, Engen P, Vitaterna MH, Turek FW, Keshavarzian A. Circadian disorganization alters intestinal microbiota. PLoS One. 2014; 9(5):e97500. PMID: 24848969.
      Citations:    
    91. Keerthivasan S, Aghajani K, Dose M, Molinero L, Khan MW, Venkateswaran V, Weber C, Emmanuel AO, Sun T, Bentrem DJ, Mulcahy M, Keshavarzian A, Ramos EM, Blatner N, Khazaie K, Gounari F. ?-Catenin promotes colitis and colon cancer through imprinting of proinflammatory properties in T cells. Sci Transl Med. 2014 Feb 26; 6(225):225ra28. PMID: 24574339.
      Citations:    
    92. Mutlu EA, Keshavarzian A, Losurdo J, Swanson G, Siewe B, Forsyth C, French A, Demarais P, Sun Y, Koenig L, Cox S, Engen P, Chakradeo P, Abbasi R, Gorenz A, Burns C, Landay A. A compositional look at the human gastrointestinal microbiome and immune activation parameters in HIV infected subjects. PLoS Pathog. 2014 Feb; 10(2):e1003829. PMID: 24586144.
      Citations:    
    93. Gandhi S, Jedel S, Hood MM, Mutlu E, Swanson G, Keshavarzian A. The relationship between coping, health competence and patient participation among patients with inactive inflammatory bowel disease. J Crohns Colitis. 2014 05; 8(5):401-8. PMID: 24230968.
      Citations:    
    94. Kelly LP, Carvey PM, Keshavarzian A, Shannon KM, Shaikh M, Bakay RA, Kordower JH. Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease. Mov Disord. 2014 Jul; 29(8):999-1009. PMID: 24898698.
      Citations:    
    95. Yang J, Mart?nez I, Walter J, Keshavarzian A, Rose DJ. In?vitro characterization of the impact of selected dietary fibers on fecal microbiota composition and short chain fatty acid production. Anaerobe. 2013 Oct; 23:74-81. PMID: 23831725.
      Citations:    
    96. Skarupski KA, Keshavarzian A. Investing in academic medicine research mentoring: low cost, high return. Gastroenterology. 2013 Apr; 144(4):e21-2. PMID: 23462123.
      Citations:    
    97. Wimberly AL, Forsyth CB, Khan MW, Pemberton A, Khazaie K, Keshavarzian A. Ethanol-induced mast cell-mediated inflammation leads to increased susceptibility of intestinal tumorigenesis in the APC ?468 min mouse model of colon cancer. Alcohol Clin Exp Res. 2013 Jan; 37 Suppl 1:E199-208. PMID: 23320800.
      Citations:    
    98. Yazici C, Losurdo J, Brown MD, Oosterveen S, Rahimi R, Keshavarzian A, Bozorgnia L, Mutlu E. Inpatient capsule endoscopy leads to frequent incomplete small bowel examinations. World J Gastroenterol. 2012 Sep 28; 18(36):5051-7. PMID: 23049213.
      Citations:    
    99. Jedel S, Hankin V, Voigt RM, Keshavarzian A. Addressing the mind, body, and spirit in a gastrointestinal practice for inflammatory bowel disease patients. Clin Gastroenterol Hepatol. 2012 Mar; 10(3):244-6. PMID: 22172296.
      Citations:    
    100. Tang Y, Forsyth CB, Keshavarzian A. New molecular insights into inflammatory bowel disease-induced diarrhea. Expert Rev Gastroenterol Hepatol. 2011 Oct; 5(5):615-25. PMID: 21910579.
      Citations:    
    101. Swanson GR, Tieu V, Shaikh M, Forsyth C, Keshavarzian A. Is moderate red wine consumption safe in inactive inflammatory bowel disease? Digestion. 2011; 84(3):238-44. PMID: 21876358.
      Citations:    
    102. Shannon KM, Keshavarzian A, Mutlu E, Dodiya HB, Daian D, Jaglin JA, Kordower JH. Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease. Mov Disord. 2012 May; 27(6):709-15. PMID: 21766334.
      Citations:    
    103. Mutlu EA, Engen PA, Soberanes S, Urich D, Forsyth CB, Nigdelioglu R, Chiarella SE, Radigan KA, Gonzalez A, Jakate S, Keshavarzian A, Budinger GR, Mutlu GM. Particulate matter air pollution causes oxidant-mediated increase in gut permeability in mice. Part Fibre Toxicol. 2011 Jun 09; 8:19. PMID: 21658250.
      Citations:    
    104. Forsyth CB, Tang Y, Shaikh M, Zhang L, Keshavarzian A. Role of snail activation in alcohol-induced iNOS-mediated disruption of intestinal epithelial cell permeability. Alcohol Clin Exp Res. 2011 Sep; 35(9):1635-43. PMID: 21535025.
      Citations:    
    105. Swanson G, Forsyth CB, Tang Y, Shaikh M, Zhang L, Turek FW, Keshavarzian A. Role of intestinal circadian genes in alcohol-induced gut leakiness. Alcohol Clin Exp Res. 2011 Jul; 35(7):1305-14. PMID: 21463335.
      Citations:    
    106. Singhal S, Dian D, Keshavarzian A, Fogg L, Fields JZ, Farhadi A. The role of oral hygiene in inflammatory bowel disease. Dig Dis Sci. 2011 Jan; 56(1):170-5. PMID: 20458622.
      Citations:    
    107. Naqvi A, Rangwala H, Keshavarzian A, Gillevet P. Network-based modeling of the human gut microbiome. Chem Biodivers. 2010 May; 7(5):1040-50. PMID: 20491063.
      Citations:    
    108. Hayden DM, Forsyth C, Keshavarzian A. The role of matrix metalloproteinases in intestinal epithelial wound healing during normal and inflammatory states. J Surg Res. 2011 Jun 15; 168(2):315-24. PMID: 20655064.
      Citations:    
    109. Sohrabpour AA, Malekzadeh R, Keshavarzian A. Current therapeutic approaches in inflammatory bowel disease. Curr Pharm Des. 2010; 16(33):3668-83. PMID: 21128898.
      Citations:    
    110. Rose DJ, Venema K, Keshavarzian A, Hamaker BR. Starch-entrapped microspheres show a beneficial fermentation profile and decrease in potentially harmful bacteria during in vitro fermentation in faecal microbiota obtained from patients with inflammatory bowel disease. Br J Nutr. 2010 May; 103(10):1514-24. PMID: 20021704.
      Citations:    
    111. Forsyth CB, Tang Y, Shaikh M, Zhang L, Keshavarzian A. Alcohol stimulates activation of Snail, epidermal growth factor receptor signaling, and biomarkers of epithelial-mesenchymal transition in colon and breast cancer cells. Alcohol Clin Exp Res. 2010 Jan; 34(1):19-31. PMID: 19860811.
      Citations:    
    112. Tang Y, Forsyth CB, Farhadi A, Rangan J, Jakate S, Shaikh M, Banan A, Fields JZ, Keshavarzian A. Nitric oxide-mediated intestinal injury is required for alcohol-induced gut leakiness and liver damage. Alcohol Clin Exp Res. 2009 Jul; 33(7):1220-30. PMID: 19389191.
      Citations:    
    113. Forsyth CB, Farhadi A, Jakate SM, Tang Y, Shaikh M, Keshavarzian A. Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis. Alcohol. 2009 Mar; 43(2):163-72. PMID: 19251117.
      Citations:    
    114. Haddish-Berhane N, Farhadi A, Nyquist C, Haghighi K, Keshavarzian A. SIMDOT-AbMe: microphysiologically based simulation tool for quantitative prediction of systemic and local bioavailability of targeted oral delivery formulations. Drug Metab Dispos. 2009 Mar; 37(3):608-18. PMID: 19047471.
      Citations:    
    115. Preuss F, Tang Y, Laposky AD, Arble D, Keshavarzian A, Turek FW. Adverse effects of chronic circadian desynchronization in animals in a "challenging" environment. Am J Physiol Regul Integr Comp Physiol. 2008 Dec; 295(6):R2034-40. PMID: 18843092.
      Citations:    
    116. Ranjbaran Z, Keefer L, Farhadi A, Stepanski E, Sedghi S, Keshavarzian A. Impact of sleep disturbances in inflammatory bowel disease. J Gastroenterol Hepatol. 2007 Nov; 22(11):1748-53. PMID: 17914945.
      Citations:    
    117. Melson J, Jakate S, Fung H, Arai S, Keshavarzian A. Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease. Am J Hematol. 2007 Oct; 82(10):881-6. PMID: 17570511.
      Citations:    
    118. Keefer L, Keshavarzian A. Feasibility and acceptability of gut-directed hypnosis on inflammatory bowel disease: a brief communication. Int J Clin Exp Hypn. 2007 Oct; 55(4):457-66. PMID: 17786661.
      Citations:    
    119. Banan A, Keshavarzian A, Zhang L, Shaikh M, Forsyth CB, Tang Y, Fields JZ. NF-kappaB activation as a key mechanism in ethanol-induced disruption of the F-actin cytoskeleton and monolayer barrier integrity in intestinal epithelium. Alcohol. 2007 Sep; 41(6):447-60. PMID: 17869053.
      Citations:    
    120. Farhadi A, Keshavarzian A, Fields JZ, Jakate S, Shaikh M, Banan A. Reduced immunostaining for c-kit receptors in mucosal mast cells in inflammatory bowel disease. J Gastroenterol Hepatol. 2007 Dec; 22(12):2338-43. PMID: 17645464.
      Citations:    
    121. Farhadi A, Forsyth C, Banan A, Shaikh M, Engen P, Fields JZ, Keshavarzian A. Evidence for non-chemical, non-electrical intercellular signaling in intestinal epithelial cells. Bioelectrochemistry. 2007 Nov; 71(2):142-8. PMID: 17428745.
      Citations:    
    122. Rose DJ, DeMeo MT, Keshavarzian A, Hamaker BR. Influence of dietary fiber on inflammatory bowel disease and colon cancer: importance of fermentation pattern. Nutr Rev. 2007 Feb; 65(2):51-62. PMID: 17345958.
      Citations:    
    123. Forsyth CB, Banan A, Farhadi A, Fields JZ, Tang Y, Shaikh M, Zhang LJ, Engen PA, Keshavarzian A. Regulation of oxidant-induced intestinal permeability by metalloprotease-dependent epidermal growth factor receptor signaling. J Pharmacol Exp Ther. 2007 Apr; 321(1):84-97. PMID: 17220428.
      Citations:    
    124. Kaplan M, Mutlu EA, Benson M, Fields JZ, Banan A, Keshavarzian A. Use of herbal preparations in the treatment of oxidant-mediated inflammatory disorders. Complement Ther Med. 2007 Sep; 15(3):207-16. PMID: 17709066.
      Citations:    
    125. Mutlu EA, Keshavarzian A, Mutlu GM. Hyperalbuminemia and elevated transaminases associated with high-protein diet. Scand J Gastroenterol. 2006 Jun; 41(6):759-60. PMID: 16716979.
      Citations:    
    126. Farhadi A, Keshavarzian A, Fields JZ, Sheikh M, Banan A. Resolution of common dietary sugars from probe sugars for test of intestinal permeability using capillary column gas chromatography. J Chromatogr B Analyt Technol Biomed Life Sci. 2006 May 19; 836(1-2):63-8. PMID: 16621740.
      Citations:    
    127. Jakate S, Demeo M, John R, Tobin M, Keshavarzian A. Mastocytic enterocolitis: increased mucosal mast cells in chronic intractable diarrhea. Arch Pathol Lab Med. 2006 Mar; 130(3):362-7. PMID: 16519565.
      Citations:    
    128. Haddish-Berhane N, Nyquist C, Haghighi K, Corvalan C, Keshavarzian A, Campanella O, Rickus J, Farhadi A. A multi-scale stochastic drug release model for polymer-coated targeted drug delivery systems. J Control Release. 2006 Jan 10; 110(2):314-322. PMID: 16288814.
      Citations:    
    129. Banan A, Zhang LJ, Shaikh M, Fields JZ, Choudhary S, Forsyth CB, Farhadi A, Keshavarzian A. theta Isoform of protein kinase C alters barrier function in intestinal epithelium through modulation of distinct claudin isotypes: a novel mechanism for regulation of permeability. J Pharmacol Exp Ther. 2005 Jun; 313(3):962-82. PMID: 15900076.
      Citations:    
    130. Ren JC, Banan A, Keshavarzian A, Zhu Q, Lapaglia N, McNulty J, Emanuele NV, Emanuele MA. Exposure to ethanol induces oxidative damage in the pituitary gland. Alcohol. 2005 Feb; 35(2):91-101. PMID: 15963422.
      Citations:    
    131. Frantzides CT, Carlson MA, Moore RE, Zografakis JG, Madan AK, Puumala S, Keshavarzian A. Effect of body mass index on nonalcoholic fatty liver disease in patients undergoing minimally invasive bariatric surgery. J Gastrointest Surg. 2004 Nov; 8(7):849-55. PMID: 15531238.
      Citations:    
    132. Frantzides CT, Madan AK, Moore RE, Zografakis JG, Carlson MA, Keshavarzian A. Laparoscopic transgastric esophageal mucosal resection for high-grade dysplasia. J Laparoendosc Adv Surg Tech A. 2004 Oct; 14(5):261-5. PMID: 15630939.
      Citations:    
    133. Banan A, Zhang LJ, Shaikh M, Fields JZ, Farhadi A, Keshavarzian A. Inhibition of oxidant-induced nuclear factor-kappaB activation and inhibitory-kappaBalpha degradation and instability of F-actin cytoskeletal dynamics and barrier function by epidermal growth factor: key role of phospholipase-gamma isoform. J Pharmacol Exp Ther. 2004 Apr; 309(1):356-68. PMID: 14724221.
      Citations:    
    134. Frantzides CT, Moore RE, Carlson MA, Madan AK, Zografakis JG, Keshavarzian A, Smith C. Minimally invasive surgery for achalasia: a 10-year experience. J Gastrointest Surg. 2004 Jan; 8(1):18-23. PMID: 14746831.
      Citations:    
    135. Banan A, Zhang LJ, Farhadi A, Fields JZ, Shaikh M, Keshavarzian A. PKC-beta1 isoform activation is required for EGF-induced NF-kappaB inactivation and IkappaBalpha stabilization and protection of F-actin assembly and barrier function in enterocyte monolayers. Am J Physiol Cell Physiol. 2004 Mar; 286(3):C723-38. PMID: 14602581.
      Citations:    
    136. Kaplan M, Mutlu EA, Jakate S, Bruninga K, Losurdo J, Losurdo J, Keshavarzian A. Endoscopy in eosinophilic esophagitis: "feline" esophagus and perforation risk. Clin Gastroenterol Hepatol. 2003 Nov; 1(6):433-7. PMID: 15017642.
      Citations:    
    137. Keshavarzian A, Fields J. Alcoholic liver disease: is it an "extraintestinal" complication of alcohol-induced intestinal injury? J Lab Clin Med. 2003 Nov; 142(5):285-7. PMID: 14647031.
      Citations:    
    138. Banan A, Fields JZ, Zhang LJ, Shaikh M, Farhadi A, Keshavarzian A. Zeta isoform of protein kinase C prevents oxidant-induced nuclear factor-kappaB activation and I-kappaBalpha degradation: a fundamental mechanism for epidermal growth factor protection of the microtubule cytoskeleton and intestinal barrier integrity. J Pharmacol Exp Ther. 2003 Oct; 307(1):53-66. PMID: 12893839.
      Citations:    
    139. Bhattacharya B, Jakate S, Saclarides TJ, Keshavarzian A. Gastric heterotopia presenting as a mass in jejunum. Arch Pathol Lab Med. 2003 Apr; 127(4):506-7. PMID: 12683890.
      Citations:    
    140. Banan A, Farhadi A, Fields JZ, Zhang LJ, Shaikh M, Keshavarzian A. The delta-isoform of protein kinase C causes inducible nitric-oxide synthase and nitric oxide up-regulation: key mechanism for oxidant-induced carbonylation, nitration, and disassembly of the microtubule cytoskeleton and hyperpermeability of barrier of intestinal epithelia. J Pharmacol Exp Ther. 2003 May; 305(2):482-94. PMID: 12606598.
      Citations:    
    141. Alnadjim Z, Kayali Z, Haddad W, Holmes EW, Keshavarzian A, Mittal N, Ivancic D, Koehler R, Goldsmith D, Waltenbaugh C, Barrett TA. Differential effects of T-cell activation on gastric and small bowel permeability in alcohol-consuming mice. Alcohol Clin Exp Res. 2002 Sep; 26(9):1436-43. PMID: 12351940.
      Citations:    
    142. Komanduri S, Jakate S, Keshavarzian A. Focal rectal capillaritis: microscopic polyangiitis presenting as painless rectal bleeding. J Clin Gastroenterol. 2002 Aug; 35(2):157-9. PMID: 12172362.
      Citations:    
    143. Farhadi A, Keshavarzian A, Fitzpatrick LR, Mutlu E, Zhang Y, Banan A. Modulatory effects of plasma and colonic milieu of patients with ulcerative colitis on neutrophil reactive oxygen species production in presence of a novel antioxidant, rebamipide. Dig Dis Sci. 2002 Jun; 47(6):1342-8. PMID: 12064811.
      Citations:    
    144. Mutlu EA, Farhadi A, Keshavarzian A. New developments in the treatment of inflammatory bowel disease. Expert Opin Investig Drugs. 2002 Mar; 11(3):365-85. PMID: 11866666.
      Citations:    
    145. Keshavarzian A, Choudhary S, Holmes EW, Yong S, Banan A, Jakate S, Fields JZ. Preventing gut leakiness by oats supplementation ameliorates alcohol-induced liver damage in rats. J Pharmacol Exp Ther. 2001 Nov; 299(2):442-8. PMID: 11602653.
      Citations:    
    146. Choudhary S, Keshavarzian A, Yong S, Wade M, Bocckino S, Day BJ, Banan A. Novel antioxidants zolimid and AEOL11201 ameliorate colitis in rats. Dig Dis Sci. 2001 Oct; 46(10):2222-30. PMID: 11680601.
      Citations:    
    147. Banan A, Fields JZ, Zhang Y, Keshavarzian A. Phospholipase C-gamma inhibition prevents EGF protection of intestinal cytoskeleton and barrier against oxidants. Am J Physiol Gastrointest Liver Physiol. 2001 Aug; 281(2):G412-23. PMID: 11447022.
      Citations:    
    148. Farhadi A, Bruninga K, Fields J, Keshavarzian A. Irritable bowel syndrome: an update on therapeutic modalities. Expert Opin Investig Drugs. 2001 Jul; 10(7):1211-22. PMID: 11772245.
      Citations:    
    149. Bu P, Keshavarzian A, Stone DD, Liu J, Le PT, Fisher S, Qiao L. Apoptosis: one of the mechanisms that maintains unresponsiveness of the intestinal mucosal immune system. J Immunol. 2001 May 15; 166(10):6399-403. PMID: 11342665.
      Citations:    
    150. Banan A, Fields JZ, Zhang Y, Keshavarzian A. Key role of PKC and Ca2+ in EGF protection of microtubules and intestinal barrier against oxidants. Am J Physiol Gastrointest Liver Physiol. 2001 May; 280(5):G828-43. PMID: 11292590.
      Citations:    
    151. Kennedy M, Bruninga K, Mutlu EA, Losurdo J, Choudhary S, Keshavarzian A. Successful and sustained treatment of chronic radiation proctitis with antioxidant vitamins E and C. Am J Gastroenterol. 2001 Apr; 96(4):1080-4. PMID: 11316150.
      Citations:    
    152. Mathurin P, Deng QG, Keshavarzian A, Choudhary S, Holmes EW, Tsukamoto H. Exacerbation of alcoholic liver injury by enteral endotoxin in rats. Hepatology. 2000 Nov; 32(5):1008-17. PMID: 11050051.
      Citations:    
    153. Banan A, Fields JZ, Decker H, Zhang Y, Keshavarzian A. Nitric oxide and its metabolites mediate ethanol-induced microtubule disruption and intestinal barrier dysfunction. J Pharmacol Exp Ther. 2000 Sep; 294(3):997-1008. PMID: 10945852.
      Citations:    
    154. Banan A, Zhang Y, Losurdo J, Keshavarzian A. Carbonylation and disassembly of the F-actin cytoskeleton in oxidant induced barrier dysfunction and its prevention by epidermal growth factor and transforming growth factor alpha in a human colonic cell line. Gut. 2000 Jun; 46(6):830-7. PMID: 10807896.
      Citations:    
    155. Banan A, Choudhary S, Zhang Y, Fields JZ, Keshavarzian A. Oxidant-induced intestinal barrier disruption and its prevention by growth factors in a human colonic cell line: role of the microtubule cytoskeleton. Free Radic Biol Med. 2000 Mar 01; 28(5):727-38. PMID: 10754268.
      Citations:    
    156. Banan A, Choudhary S, Zhang Y, Fields JZ, Keshavarzian A. Ethanol-induced barrier dysfunction and its prevention by growth factors in human intestinal monolayers: evidence for oxidative and cytoskeletal mechanisms. J Pharmacol Exp Ther. 1999 Dec; 291(3):1075-85. PMID: 10565827.
      Citations:    
    157. Keshavarzian A, Fusunyan RD, Jacyno M, Winship D, MacDermott RP, Sanderson IR. Increased interleukin-8 (IL-8) in rectal dialysate from patients with ulcerative colitis: evidence for a biological role for IL-8 in inflammation of the colon. Am J Gastroenterol. 1999 Mar; 94(3):704-12. PMID: 10086655.
      Citations:    
    158. Robinson CE, Keshavarzian A, Pasco DS, Frommel TO, Winship DH, Holmes EW. Determination of protein carbonyl groups by immunoblotting. Anal Biochem. 1999 Jan 01; 266(1):48-57. PMID: 9887212.
      Citations:    
    159. Holmes EW, Yong SL, Eiznhamer D, Keshavarzian A. Glutathione content of colonic mucosa: evidence for oxidative damage in active ulcerative colitis. Dig Dis Sci. 1998 May; 43(5):1088-95. PMID: 9590426.
      Citations:    
    160. Aranha GV, Walsh RM, Jacobs HK, Freeark RJ, Harford FJ, Keshavarzian A, Zarling EJ. Factors influencing bowel function following total abdominal colectomy. Dis Colon Rectum. 1996 Dec; 39(12):1418-22. PMID: 8969669.
      Citations:    
    161. Zarif A, Eiznhamer D, Callaghan C, Doria MI, Broutman L, Keshavarzian A. The effect of a selective 5-lipoxygenase inhibitor, zileuton, on tissue damage in acute colonic inflammation in rats. Inflammation. 1996 Jun; 20(3):217-27. PMID: 8796377.
      Citations:    
    162. Fields JZ, Jacyno M, Wasyliw R, Winship D, Keshavarzian A. Ethanol inhibits contractility of esophageal smooth muscle strips. Alcohol Clin Exp Res. 1995 Dec; 19(6):1403-13. PMID: 8749802.
      Citations:    
    163. Haydek JM, Keshavarzian A. Circulating neutrophils from patients with ulcerative colitis have a normal respiratory burst. Inflammation. 1995 Dec; 19(6):701-15. PMID: 8595936.
      Citations:    
    164. Keshavarzian A, Barnes WE, Bruninga K, Nemchausky B, Mermall H, Bushnell D. Delayed colonic transit in spinal cord-injured patients measured by indium-111 Amberlite scintigraphy. Am J Gastroenterol. 1995 Aug; 90(8):1295-300. PMID: 7639233.
      Citations:    
    165. Keshavarzian A, Fields JZ, Vaeth J, Holmes EW. The differing effects of acute and chronic alcohol on gastric and intestinal permeability. Am J Gastroenterol. 1994 Dec; 89(12):2205-11. PMID: 7977243.
      Citations:    
    166. Keshavarzian A, Zorub O, Sayeed M, Urban G, Sweeney C, Winship D, Fields J. Acute ethanol inhibits calcium influxes into esophageal smooth but not striated muscle: a possible mechanism for ethanol-induced inhibition of esophageal contractility. J Pharmacol Exp Ther. 1994 Sep; 270(3):1057-62. PMID: 7932153.
      Citations:    
    167. Firouzi M, Keshavarzian A. Guillain-Barre syndrome and achalasia: two manifestations of a viral disease or coincidental association? Am J Gastroenterol. 1994 Sep; 89(9):1585-7. PMID: 8079948.
      Citations:    
    168. Fields JZ, Turk A, Durkin M, Ravi NV, Keshavarzian A. Increased gastrointestinal symptoms in chronic alcoholics. Am J Gastroenterol. 1994 Mar; 89(3):382-6. PMID: 8122650.
      Citations:    
    169. Stinneford JG, Keshavarzian A, Nemchausky BA, Doria MI, Durkin M. Esophagitis and esophageal motor abnormalities in patients with chronic spinal cord injuries. Paraplegia. 1993 Jun; 31(6):384-92. PMID: 8337002.
      Citations:    
    170. Keshavarzian A, Haydek J, Zabihi R, Doria M, D'Astice M, Sorenson JR. Agents capable of eliminating reactive oxygen species. Catalase, WR-2721, or Cu(II)2(3,5-DIPS)4 decrease experimental colitis. Dig Dis Sci. 1992 Dec; 37(12):1866-73. PMID: 1335406.
      Citations:    
    171. Keshavarzian A, Doria MI, Sedghi S, Kanofsky JR, Hecht D, Holmes EW, Ibrahim C, List T, Urban G, Gaginella T, et al. Mitomycin C-induced colitis in rats: a new animal model of acute colonic inflammation implicating reactive oxygen species. J Lab Clin Med. 1992 Nov; 120(5):778-91. PMID: 1431507.
      Citations:    
    172. Keshavarzian A, Sedghi S, Kanofsky J, List T, Robinson C, Ibrahim C, Winship D. Excessive production of reactive oxygen metabolites by inflamed colon: analysis by chemiluminescence probe. Gastroenterology. 1992 Jul; 103(1):177-85. PMID: 1612325.
      Citations:    
    173. Keshavarzian A, Gordon JH, Willson C, Urban G, Fields JZ. Chronic ethanol feeding produces a muscarinic receptor upregulation, but not a muscarinic supersensitivity in lower esophageal sphincter muscle. J Pharmacol Exp Ther. 1992 Feb; 260(2):601-7. PMID: 1346638.
      Citations:    
    174. Klamut MJ, Keshavarzian A. Stress ulcer. J Assoc Acad Minor Phys. 1992; 3(3):89-94. PMID: 1498526.
      Citations:    
    175. Steck TB, Costanzo-Nordin MR, Keshavarzian A. Prevalence and management of cholelithiasis in heart transplant patients. J Heart Lung Transplant. 1991 Nov-Dec; 10(6):1029-32. PMID: 1756150.
      Citations:    
    176. Keshavarzian A, Bushnell DL, Sontag S, Yegelwel EJ, Smid K. Gastric emptying in patients with severe reflux esophagitis. Am J Gastroenterol. 1991 Jun; 86(6):738-42. PMID: 2038997.
      Citations:    
    177. Keshavarzian A, Polepalle C, Iber FL, Durkin M. Esophageal motor disorder in alcoholics: result of alcoholism or withdrawal? Alcohol Clin Exp Res. 1990 Aug; 14(4):561-7. PMID: 2221284.
      Citations:    
    178. Keshavarzian A, Schoenau G, Isaac R. Percutaneous endoscopic gastrostomy tube placement in cats. Lab Anim Sci. 1989 Sep; 39(5):459-61. PMID: 2811293.
      Citations:    
    179. Keshavarzian A, Dutta SK. Carbohydrate malabsorption in alcoholic pancreatic insufficiency. The effect of pancreatic enzyme therapy on intestinal transit time. J Clin Gastroenterol. 1988 Oct; 10(5):528-32. PMID: 2460519.
      Citations:    
    180. Chadwick VS, Mellor DM, Myers DB, Selden AC, Keshavarzian A, Broom MF, Hobson CH. Production of peptides inducing chemotaxis and lysosomal enzyme release in human neutrophils by intestinal bacteria in vitro and in vivo. Scand J Gastroenterol. 1988 Jan; 23(1):121-8. PMID: 3278364.
      Citations:    
    181. Keshavarzian A, Sladen GE, Isaacs PE. Selection of patients for jejunal biopsy. Dig Dis Sci. 1987 Jun; 32(6):669. PMID: 3568955.
      Citations:    
    182. Keshavarzian A, Iber FL, Greer P, Wobbleton J. Gastric emptying of solid meal in male chronic alcoholics. Alcohol Clin Exp Res. 1986 Aug; 10(4):432-5. PMID: 3530022.
      Citations:    
    183. Keshavarzian A, Iber FL, Dangleis MD, Cornish R. Intestinal-transit and lactose intolerance in chronic alcoholics. Am J Clin Nutr. 1986 Jul; 44(1):70-6. PMID: 3728351.
      Citations:    
    184. Keshavarzian A, Iber FL. Intestinal transit in insulin-requiring diabetics. Am J Gastroenterol. 1986 Apr; 81(4):257-60. PMID: 3962951.
      Citations:    
    185. Keshavarzian A, Gibson R, Guest J, Spencer J, Lavender JP, Hodgson HJ. Granulocyte migration in uncomplicated intestinal anastomosis in man. Dig Dis Sci. 1986 Mar; 31(3):268-72. PMID: 3948630.
      Citations:    
    186. Keshavarzian A, Price YE, Peters AM, Lavender JP, Wright NA, Hodgson HJ. Specificity of indium-111 granulocyte scanning and fecal excretion measurement in inflammatory bowel disease--an autoradiographic study. Dig Dis Sci. 1985 Dec; 30(12):1156-60. PMID: 4064866.
      Citations:    
    187. Isaacs JD, Keshavarzian A, Blumgart LH, Hodgson HJ. Juvenile chronic pancreatitis--a cause of painless jaundice in a patient with multiple somatic abnormalities. J Clin Gastroenterol. 1985 Dec; 7(6):533-6. PMID: 4086750.
      Citations:    
    188. Keshavarzian A, Isaacs P, McColl I, Sladen GE. Idiopathic intestinal pseudo-obstruction and contaminated small bowel syndrome--treatment with metronidazole, ileostomy, and indomethacin. Am J Gastroenterol. 1983 Sep; 78(9):562-5. PMID: 6688501.
      Citations:    
    Keshavarzian's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (778)
    Explore
    _
    Co-Authors (43)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _